Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Nasonex Delivery Failures Are Among Observations In Schering FDA-483s

Jun 25 2001

• By The Pink Sheet

Related Content

Schering Reinspection Brings New FDA-483s: Firm Updates Compliance Plans

Jun 25 2001

Schering-Plough Asmanex

Mar 05 2001

Claritin Supply Sufficient For Spring, Schering Says; FDA Lists GMP Problems

Mar 05 2001

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window